Hamill Laura is a director of Pardes Biosciences Inc.
Person profile
Roles
Pardes Biosciences
Director
Y-Mabs Therapeutics
Director
Scilex Holding
Director
AnaptysBio
Director
Address
Foster City, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
PARDES BIOSCIENCES, INC.
31 Aug 23
4
Y-mAbs Therapeutics, Inc.
9 Jun 23
4
PARDES BIOSCIENCES, INC.
2 Jun 23
4
Scilex Holding Co
17 Jan 23
4
ANAPTYSBIO, INC
10 Jan 23
3
Vickers Vantage Corp. I
15 Nov 22
4
Y-mAbs Therapeutics, Inc.
19 Jul 22
4
PARDES BIOSCIENCES, INC.
10 Jun 22
4
ANAPTYSBIO, INC
14 Feb 22
4
PARDES BIOSCIENCES, INC.
28 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Aug 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.21 | 37,500 | 195.38 k | 0 |
31 Aug 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 9.8 | 75,000 | 735.00 k | 0 |
31 Aug 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 4.94 | 70,390 | 347.73 k | 0 |
31 Aug 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.87 | 37,500 | 70.13 k | 0 |
8 Jun 23 | YMAB Y-Mabs Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,330 | 0.00 | 2,330 |
8 Jun 23 | YMAB Y-Mabs Therapeutics | Employee Stock Option Common stock | Grant | Acquire A | No | No | 8.13 | 13,950 | 113.41 k | 13,950 |
1 Jun 23 | PRDS Pardes Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 1.87 | 37,500 | 70.13 k | 37,500 |
17 Jan 23 | SCLX Scilex Holding | Nonstatutory Stock Option Common Stock | Grant | Acquire A | No | No | 8.08 | 250,000 | 2.02 mm | 250,000 |
6 Jan 23 | ANAB AnaptysBio | RSU Common Stock | Grant | Acquire A | No | No | 0 | 3,900 | 0.00 | 3,900 |
6 Jan 23 | ANAB AnaptysBio | Stock Option Common Stock | Grant | Acquire A | No | No | 23.23 | 10,600 | 246.24 k | 10,600 |